What Encompass Health (EHC) Investors Need to Know

One of the losers of today's trading session was Encompass Health. Shares of the Services-hospitals company plunged -5.66%, and some investors may be wondering if its price of $56.72 would make a good entry point. Here's what you should know if you are considering this investment:

  • Encompass Health has moved 15.08% over the last year, and the S&P 500 logged a change of -7.524395%

  • EHC has an average analyst rating of strong buy and is -20.62% away from its mean target price of $71.45 per share

  • Its trailing earnings per share (EPS) is $2.56

  • Encompass Health has a trailing 12 month Price to Earnings (P/E) ratio of 22.15 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $3.53 and its forward P/E ratio is 16.07

  • The company has a Price to Book (P/B) ratio of 4.605 in contrast to the S&P 500's average ratio of 2.95

  • Encompass Health is part of the Basic Materials sector, which has an average P/E ratio of 10.03 and an average P/B of 2.08

  • Encompass Health Corporation offers in-home and post-acute health care services in the United States. The company is headquartered in Birmingham, Alabama.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.